|
Anticoagulatie in complex patients
Expired
This course is expired
Covid19 and (anti)coagulation: what have we learned? DOACs, Diabetes, and Atrial Fibrillation: The Good, the Bad and the Ugly- Anno 2021 Anticoagulation in cancer patients with atrial fibrillation.

Chapters
-
1Play video
-
2Result
-
1In type 2 diabetes, the risk of developing atrial fibrillation is
-
2When formulating a treatment okan for AF (atrial fibrillation):
-
3Type 2 diabetes with micro and macrovascular complications (co-morbid diabetes)
-
4Result

Chapters
-
1Play video
-
2Result
-
1In type 2 diabetes, the risk of developing atrial fibrillation is
-
2When formulating a treatment okan for AF (atrial fibrillation):
-
3Type 2 diabetes with micro and macrovascular complications (co-morbid diabetes)
-
4Result